Atea Pharmaceuticals Future Growth
How is Atea Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
-8.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 78 | -219 | N/A | N/A | 1 |
| 12/31/2024 | 230 | -119 | 101 | 116 | 3 |
| 12/31/2023 | N/A | -226 | -257 | -240 | 3 |
| 9/30/2022 | 192 | 36 | -177 | -175 | N/A |
| 6/30/2022 | 225 | 16 | -133 | -131 | N/A |
| 3/31/2022 | 285 | 48 | -129 | -129 | N/A |
| 12/31/2021 | 351 | 121 | -87 | -87 | N/A |
| 9/30/2021 | 208 | 25 | 307 | 307 | N/A |
| 6/30/2021 | 175 | 35 | 275 | 275 | N/A |
| 3/31/2021 | 115 | 24 | 284 | 284 | N/A |
| 12/31/2020 | 49 | -11 | 297 | 297 | N/A |
| 9/30/2020 | N/A | -36 | -26 | -26 | N/A |
| 6/30/2020 | N/A | -22 | -20 | -20 | N/A |
| 3/31/2020 | N/A | -16 | -14 | -14 | N/A |
| 12/31/2019 | N/A | -14 | -13 | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVIR's earnings are forecast to decline over the next 3 years (-8.3% per year).
Earnings vs Market: AVIR's earnings are forecast to decline over the next 3 years (-8.3% per year).
High Growth Earnings: AVIR's earnings are forecast to decline over the next 3 years.
Revenue vs Market: AVIR is forecast to have no revenue next year.
High Growth Revenue: AVIR is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AVIR is forecast to be unprofitable in 3 years.